Re:The French way of cancer treatment
by mikeash on Saturday February 15, 2014 @05:08AM
(#7243309)
US medical R&D spending is about $500/year per capita. US overspending on medical care compared to other first-world countries is about $3000/year per capita. That doesn't account for more than a small part.
[ Parent
| on HN ]
That's a fair point, but R&D isn't the only thing encouraging the development of new drugs and technologies. A huge market willing to "overpay" is a massive driver. Look at the history of MRI penetration in Canada vs. the U.S. for an oft-used example.
Anecdotally, I've been told of pharmaceuticals that only get cleared for future development because the expected U.S. pricing will make them viable.
> Anecdotally, I've been told of pharmaceuticals that only get cleared for future development because the expected U.S. pricing will make them viable.
That doesn't mean those meds are effective or even not actively harmful. People willing to pay tens of thousands of dollars to gamble on getting an extra 4 weeks of shitty quality life doesn't sound like a good way to run medication development.